RDIF invests in the supplier of diagnostic tests for the detection of coronavirus "Medpromresurs" LLC

Press release, 19.03.2020

Moscow, March 19, 2020 – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, has invested in the Russian company “Medpromresurs” LLC, the Fund’s partners in this company are К.K. Mirai Genomics (Japan), as well as “Geneticheskie tekhnologii” LLC, which is owned by A.Y. Kozlov (two-thirds of the company) and Management Company “Evokorp” LLC (the beneficiary is M.V. Viktorov, owns one-third of the company).

“Medpromresurs” LLC was created to promote the new Russian-Japanese diagnostic system for the detection of the COVID-19 coronavirus, which received approval from the Federal Service for Surveillance in Healthcare (Roszdravnadzor) for use in the Russian Federation.

“Medpromresurs” LLC currently organizes the production of portable laboratories, reagents and other elements of the diagnostic system at Russian plants. The system will be used to diagnose the coronavirus or COVID-19 both in Russia and abroad.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said:

“The Russian-Japanese technology to conduct diagnostic tests for coronavirus is extremely promising to reduce the risk of coronavirus in Russia.

This technology, in which the RDIF has invested, has significant export potential. Our foreign partners have expressed interest in purchasing the diagnostic system - we have already received preliminary applications for the purchase of more than 500 thousand tests from the UAE, Saudi Arabia and Austria. We are currently awaiting the early approval of the use of tests by regulatory authorities in Europe and the Middle East.”

Alexey Kozlov, co-owner of “Geneticheskie tekhnologii LLC”, said:

“The project combines the unique potential of domestic developments with the achievements of international partners. We hope to make a significant contribution to improving the epidemiological situation in the country.”

Maxim Viktorov, owner of the “Evokorp” Management Company, said:

“Evokorp” Management Company sees a great investment potential of this project. We are confident that by working with RDIF and attracting our infrastructure, we will be able to create a solution that will attract additional interest from foreign and Russian investors. This project is an example of international investment cooperation in Russia.”


Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Currently, RDIF has experience of the successful joint implementation of more than 70 projects with foreign partners totaling more than RUB1.5 tn and covering 95% of the regions of the Russian Federation. RDIF’s portfolio of companies employs more than 800,000 people and generates revenues which equate to over 6% of Russia’s GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 15 countries that total more than $40 bn. Further information can be found at rdif.ru

For additional information contact:

Arseniy Palagin                                     Maria Shiryaevskaya / Andrew Leach

Russian Direct Investment Fund                      Hudson Sandler

Press Secretary                                           Tel: +44 (0) 20 7796 4133 

Tel: +7 495 644 34 14, ext. 2395

Mobile: +7 916 110 31 41

E-mail: arseniy.palagin@rdif.ru